30
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13292 | VDR agonist 1 | Others | Others |
VDR agonist 1 (compound 28) 是一种非甾体类维生素 D 受体 (VDR)的激动剂, 在MCF-7 细胞中测得其IC50值为 690 nM。VDR agonist 1 通过上调 p21 和 p27 的表达来抑制细胞周期,通过增加 BAX 的表达来促进细胞凋亡,降低 Bcl-2 的表达,具有治疗乳腺癌的潜力。 | |||
T78944 |
VDR agonist 2
|
||
VDR agonist 2(化合物16i)作为VDR(vitamin D receptor)激动剂,能有效抑制TGF-β1诱导的肝星状细胞(HSC)活化,并在体外和体内展现出显著的抗肝纤维化效果。 | |||
TQ0200 |
Paricalcitol
|
||
Paricalcitol 是一种 vitamin D receptor 激活剂,是一种 vitamin D 类似物,用于研究继发性甲状旁腺功能亢进,该疾病与慢性肾功能衰竭有关。 | |||
T24166 |
Inecalcitol
TX 522,TX-522,TX522,伊奈骨化醇 |
Apoptosis | Apoptosis |
Inecalcitol (TX 522) 是一种独特的维生素 D3 类似物,可诱导细胞凋亡,有抗癌活性。它是一种具有口服活性维生素 D 受体激动剂,Kd 为 0.53 nM。 | |||
T16015 |
Maxacalcitol
马沙骨化醇,22-Oxacalcitriol |
Others | Others |
Maxacalcitol (22-Oxacalcitriol) 是非血钙维生素 D3的一种类似物,是 VDR 样受体的配体。 | |||
T14856 |
Calcipotriol
MC 903,卡泊三醇,Calcipotriene |
||
Calcipotriol (MC 903) 是一种合成的 VitD3类似物,对维他命 D 受体具有高亲和力。 | |||
TQ0244 |
Calcipotriol monohydrate
钙泊三醇一水合物,卡泊三醇一水合物 |
||
Calcipotriol monohydrate 是维生素 D3 的类似物,对维生素 D 受体具有高亲和力。Calcipotriol monohydrate 可用于银屑病研究。 | |||
T6430L |
Calcifediol monohydrate
骨化二醇一水合物,25-hydroxy Vitamin D3 monohydrate |
Endogenous Metabolite | Metabolism |
Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate) 是维生素 D3 在肝中经羟基化后得到的前激素,是有效的 VDR 抑制剂。 | |||
T6112 |
Doxercalciferol
TSA 840,度骨化醇,Hectorol,1.alpha.-Hydroxyvitamin D2,1α-hydroxyvitamin D2 |
Others | Others |
Doxercalciferol (TSA 840) 是一种维生素 D2 类似物,是一种维生素 D 受体激活剂,能够阻碍肾病的进程。 | |||
T6374 |
Alfacalcidol
Bondiol,Etalpha,阿法骨化醇,1-hydroxy Vitamin D3,1.alpha.-Hydroxyvitamin D3,1-hydroxycholecalciferol |
Others | Others |
Alfacalcidol (Etalpha) 是一种维生素 D3 衍生物,是非选择性的维生素 D 受体活化剂,有用于骨质疏松研究的潜力。 | |||
T13404 | ZK168281 | Others | Others |
ZK168281 is a 25-carboxylic ester 1α,25(OH)2D3 analog and a pure antagonist of VDR (Kd of 0.1 nM). ZK168281 is an effective inhibitor of the coactivator (CoA) interaction of its receptor. | |||
T24675 |
PS121912
PS-121912,PS 121912 |
||
PS121912 is a potent and selective inhibitor of VDR-coactivator. | |||
T69676 | LG190155 | ||
LG190155 is a moderately potent VDR agonist. Vitamin D receptor (VDR) agonists are well known for their capacity to control calcium and bone metabolism and to regulate growth and differentiation of many cell types. | |||
T70151 |
MeTC7
|
||
MeTC7 is a VDR antagonist, which can be synthesized from 7-dehydrocholesterol (6) in two steps, inhibits VDR selectively, suppresses the viability of cancer cell-lines, and reduces the growth of the spontaneous transgenic TH-MYCN neuroblastoma and xenografts in vivo. | |||
T11952 |
Maxacalcitol-D6
|
Others | Others |
Maxacalcitol-D6 is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors.Maxacalcitol-D6 is the deuterated form of Maxacalcitol (22-Oxacalcitriol). | |||
T75123 |
Maxacalcitol-d
|
||
Maxacalcitol-d66是Maxacalcitol (22-Oxacalcitriol)的氘化形式,是非血钙维生素D3类似物和VDR 样受体VDR 配体。 | |||
T17292 |
ZK159222
|
Others | Others |
ZK159222 is an effective 1α,25-(OH)2D3 receptor (VDR) agonist. ZK159222 has a partial agonistic character. | |||
T27825 |
LG190178
LG-190178,LG 190178 |
||
LG190178, a vitamin D receptor (VDR) ligand, is a therapeutic agent used for the treatment of psoriasis, osteoporosis, and secondary hyperparathyroidism. | |||
T36593 |
TEI-9648
|
||
TEI-9648, a Vitamin D3 Lactone analogue, is a potent and specific vitamin D receptor (VDR) antagonist. TEI-9648 inhibits VDR/VDRE-mediated genomic actions of 1α,25(OH)2D3. TEI-9648 also inhibits HL-60 cell differentiation induced by of 1α,25(OH)2D3. TEI-9648 has the potential for bone metabolism research[1][2]. TEI-9648 (10-1000 nM) dose-dependently blocks the reciprocal changes of CD11b and CD71 expression associated with HL-60 cell differentiation induced by 1α,25(OH)2D3[1]. TEI-9648 has cons... | |||
T13590 | Calcipotriol Impurity C | Others | Others |
Calcipotriol Impurity C is the impurity of Calcipotriol. Calcipotriol is a VDR-like receptors ligand. | |||
TQ0123 |
MC 1046
Impurity A of Calcipotriol |
Others | Others |
MC 1046 is an impurity of Calcipotriol. Calcipotriol is a ligand of VDR-like receptors. | |||
T11644 |
Impurity C of Alfacalcidol
|
Others | Others |
Impurity of Alfacalcidol is an impurity of Alfacalcidol. Alfacalcidol is a non-selective VDR activator medication. | |||
T17031 | TEI-9647 | Others | Others |
TEI-9647 is a 1α,25-dihydroxy vitamin D3-26,23-lactone (1α,25-lactone) analog and is an effective VDR/vitamin D-responsive element (DRE)-mediated genomic actions antagonist. | |||
T10279 |
Alfacalcidol-D6
|
Others | Others |
Alfacalcidol-D6 is a deuterated Alfacalcidol. Alfacalcidol is a non-selective VDR activator medication. | |||
T10088 |
24R-Calcipotriol
PRI 2202 |
Others | Others |
24R-Calcipotriol(PRI 2202) is an impurity of Calcipotriol which is a ligand of VDR-like receptors. | |||
T11646 |
Impurity F of Calcipotriol
|
Others | Others |
Impurity F of Calcipotriol is a impurity of Calcipotriol. Calcipotriol (MC 903; Calcipotriene) is a ligand of VDR-like receptors. | |||
T9644 |
Triciferol
|
||
Triciferol 作为具有结合了 VDR 激动剂和 HDAC 拮抗剂活性的多重配体发挥作用。Triciferol 直接与 VDR 结合 (IC50=87 nM),在一些 1,25D 靶基因上作为具有 1,25D 样效力的激动剂发挥作用。Triciferol 诱导显著的微管蛋白高乙酰化,并增强组蛋白乙酰化。Triciferol 在体外癌细胞模型中也表现出有效的抗增殖和细胞毒性活性。 | |||
T35524 |
(1S)-Calcitriol
|
||
(1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion[1]. 3‐epi‐Calcitroic acid is an end product of (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3; 3‐epi‐1a,25(OH)2D3) metabolism by rat CYP24A1[1]. [1]. Steve Y Rhieu, et al. Metabolic stability of 3-epi-1α,25-dihydr... | |||
T11643 |
Impurity B of Calcitriol
1β,25-Dihydroxyvitamin-D3,1-Epicalcitriol |
Others | Others |
Impurity B of Calcitriol is an impurity of Calcitriol. Calcitriol is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). | |||
T83765 |
Dendrogenin A
DDA |
||
Dendrogenin A (DDA) 作为一种选择性肝X受体(LXR)调节剂(SLiM)、胆固醇环氧水解酶(ChEH; Ki = 120 nM)的抑制剂及胆固醇的活性代谢产物,通过DDA合成酶将5,6α-环氧胆固醇与组胺结合形成。DDA在非癌性人乳腺上皮细胞和上皮黑色素细胞中存在,但在多种乳腺癌细胞或黑色素瘤细胞中未发现,且在分离的人乳腺肿瘤组织中仅以低水平存在。它抑制22(R)-羟基胆固醇诱导的LXRβ和LXRα激活(分别以IC50 = 76和362 nM),但也是LXR的部分激动剂,在B16/F10小鼠黑色素瘤细胞中增加Nur77、NOR-1、LC3-I和LC3-II的蛋白水平。DDA选择性调节LXRα和LXRβ,而非孕烯X受体(PXR)、芳香烃受体(AhR)、维生素D受体(VDR)、维甲酸X受体γ(RXRγ)、维甲酸受体α(RARα)、过氧化物酶体增殖物激活受体α(PPARα)、PPARγ、糖皮质激素受体、雄激素受体、雌激素受体α(ERα)及ERβ在2.5 µM下。此外,DDA在2.5和5 µM的浓度下增加B16/F10和SK-MEL-28癌细胞中LC3-II的蛋白水平,并在2... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1086 |
Vitamin D2
Calciferol,Ergocalciferol,Ercalciol,维生素D2 |
DNA/RNA Synthesis; Endogenous Metabolite | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Vitamin D2 (Calciferol) 来源于植物或膳食补充剂,能够用作维生素 D 的补充剂。 | |||
T1135 |
Vitamin D3
维生素D3,Cholecalciferol,Colecalciferol |
Endogenous Metabolite | Metabolism |
Vitamin D3 (Cholecalciferol) 是维生素 D 的一种天然存在形式,代谢激活后可以诱导细胞分化和癌细胞增殖。 | |||
T6316 |
Calcitriol
Topitriol,Rocaltrol,Calcijex,RO215535,骨化三醇,1,25-Dihydroxyvitamin D3 |
Endogenous Metabolite | Metabolism |
Calcitriol (1,25-Dihydroxyvitamin D3) 是一种维他命 D 的代谢物,一种维他命 D 受体 (VDR) 的激动剂 (IC50=0.4 nM)。Calcitriol 增加肠道对钙和磷的吸收,并与甲状旁腺激素一起增加了骨吸收。 | |||
T6430 |
Calcifediol
25-羟基维生素 D3,U 32070E,25-hydroxy Vitamin D3,RO 8-8892,骨化二醇 |
Endogenous Metabolite | Metabolism |
Calcifediol (U 32070E) 是由维生素 D3 在肝中经羟基化后得到的前激素,是 VDR 的有效抑制剂。 |